BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 7910101)

  • 1. Regulation of interleukin-6 (IL-6) secretion in primary cultured rat astrocytes: synergism of interleukin-1 (IL-1) and pituitary adenylate cyclase activating polypeptide (PACAP).
    Gottschall PE; Tatsuno I; Arimura A
    Brain Res; 1994 Feb; 637(1-2):197-203. PubMed ID: 7910101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pituitary adenylate cyclase activating polypeptide (PACAP) and vasoactive intestinal peptide (VIP) stimulate interleukin-6 production through the third subtype of PACAP/VIP receptor in rat bone marrow-derived stromal cells.
    Cai Y; Xin X; Shim GJ; Mokuno Y; Uehara H; Yamada T; Agui T; Matsumoto K
    Endocrinology; 1997 Jun; 138(6):2515-20. PubMed ID: 9165043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide modulate endotoxin-induced IL-6 production by murine peritoneal macrophages.
    Martínez C; Delgado M; Pozo D; Leceta J; Calvo JR; Ganea D; Gomariz RP
    J Leukoc Biol; 1998 May; 63(5):591-601. PubMed ID: 9581803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit the production of inflammatory mediators by activated microglia.
    Delgado M; Leceta J; Ganea D
    J Leukoc Biol; 2003 Jan; 73(1):155-64. PubMed ID: 12525573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pituitary adenylate cyclase-activating polypeptide (PACAP) is a regulator of astrocytes: PACAP stimulates proliferation and production of interleukin 6 (IL-6), but not nerve growth factor (NGF), in cultured rat astrocyte.
    Tatsuno I; Morio H; Tanaka T; Uchida D; Hirai A; Tamura Y; Saito Y
    Ann N Y Acad Sci; 1996 Dec; 805():482-8. PubMed ID: 8993428
    [No Abstract]   [Full Text] [Related]  

  • 6. Vasoactive intestinal peptide and pituitary adenylate cyclase activating polypeptide stimulate interleukin-6 production in prostate cancer cells and prostatic epithelial cells.
    Nagakawa O; Junicho A; Akashi T; Koizumi K; Matsuda T; Fuse H; Saiki I
    Oncol Rep; 2005 Jun; 13(6):1217-21. PubMed ID: 15870945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VPAC2-R mediates the lipolytic effects of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide in primary rat adipocytes.
    Akesson L; Ahrén B; Edgren G; Degerman E
    Endocrinology; 2005 Feb; 146(2):744-50. PubMed ID: 15514088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropeptide regulation of interleukin-6 production from the pituitary: stimulation by pituitary adenylate cyclase activating polypeptide and calcitonin gene-related peptide.
    Tatsuno I; Somogyvari-Vigh A; Mizuno K; Gottschall PE; Hidaka H; Arimura A
    Endocrinology; 1991 Oct; 129(4):1797-804. PubMed ID: 1655384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide enhance IL-10 production by murine macrophages: in vitro and in vivo studies.
    Delgado M; Munoz-Elias EJ; Gomariz RP; Ganea D
    J Immunol; 1999 Feb; 162(3):1707-16. PubMed ID: 9973433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential regulation of activity-dependent neuroprotective protein in rat astrocytes by VIP and PACAP.
    Zusev M; Gozes I
    Regul Pept; 2004 Dec; 123(1-3):33-41. PubMed ID: 15518891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of the rat proopiomelanocortin gene expression in AtT-20 cells. II: Effects of the pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal polypeptide.
    Aoki Y; Iwasaki Y; Katahira M; Oiso Y; Saito H
    Endocrinology; 1997 May; 138(5):1930-4. PubMed ID: 9112389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pituitary adenylate cyclase activating polypeptide and vasoactive intestinal peptide increase cytosolic free calcium concentration in cultured rat hippocampal neurons.
    Tatsuno I; Yada T; Vigh S; Hidaka H; Arimura A
    Endocrinology; 1992 Jul; 131(1):73-81. PubMed ID: 1319331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential expression of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide receptor subtypes in clonal pituitary somatotrophs and gonadotrophs.
    Rawlings SR; Piuz I; Schlegel W; Bockaert J; Journot L
    Endocrinology; 1995 May; 136(5):2088-98. PubMed ID: 7720658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pituitary folliculo-stellate-like cell line (TtT/GF) responds to novel hypophysiotropic peptide (pituitary adenylate cyclase-activating peptide), showing increased adenosine 3',5'-monophosphate and interleukin-6 secretion and cell proliferation.
    Matsumoto H; Koyama C; Sawada T; Koike K; Hirota K; Miyake A; Arimura A; Inoue K
    Endocrinology; 1993 Nov; 133(5):2150-5. PubMed ID: 8404665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complex array of cytokines released by vasoactive intestinal peptide.
    Brenneman DE; Phillips TM; Hauser J; Hill JM; Spong CY; Gozes I
    Neuropeptides; 2003 Apr; 37(2):111-9. PubMed ID: 12747943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel hypothalamic peptide, pituitary adenylate cyclase-activating peptide, regulates the function of rat granulosa cells in vitro.
    Heindel JJ; Sneeden J; Powell CJ; Davis B; Culler MD
    Biol Reprod; 1996 Mar; 54(3):523-30. PubMed ID: 8835372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative effect of pituitary adenylate cyclase-activating polypeptide on aldosterone secretion in normal bovine and human tumorous adrenal cells.
    Bodart V; Babinski K; Ong H; De Léan A
    Endocrinology; 1997 Feb; 138(2):566-73. PubMed ID: 9002987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptors in human benign hyperplastic prostate.
    Solano RM; Carmena MJ; Carrero I; Cavallaro S; Roman F; Hueso C; Travali S; Lopez-Fraile N; Guijarro LG; Prieto JC
    Endocrinology; 1996 Jul; 137(7):2815-22. PubMed ID: 8770902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit endotoxin-induced TNF-alpha production by macrophages: in vitro and in vivo studies.
    Delgado M; Pozo D; Martinez C; Leceta J; Calvo JR; Ganea D; Gomariz RP
    J Immunol; 1999 Feb; 162(4):2358-67. PubMed ID: 9973516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pituitary adenylate cyclase activating polypeptide (PACAP) stimulates mitogen-activated protein kinase (MAPK) in cultured rat astrocytes.
    Moroo I; Tatsuno I; Uchida D; Tanaka T; Saito J; Saito Y; Hirai A
    Brain Res; 1998 Jun; 795(1-2):191-6. PubMed ID: 9622627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.